RT Journal Article
SR Electronic
T1 Chronicling menstrual cycle patterns across the reproductive lifespan with real world data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.01.09.24301041
DO 10.1101/2024.01.09.24301041
A1 Cunningham, Adam C.
A1 Pal, Lubna
A1 Wickham, Aidan P.
A1 Prentice, Carley
A1 Goddard, Frederick G. B.
A1 Klepchukova, Anna
A1 Zhaunova, Liudmila
YR 2024
UL http://medrxiv.org/content/early/2024/01/10/2024.01.09.24301041.abstract
AB Background The intricate hormonal and physiological changes of the menstrual cycle can influence health on a daily basis. Although prior studies have helped improve our understanding of the menstrual cycle, they often lack diversity in populations included, sample size, and the span of reproductive and life stages. This paper aims to describe the dynamic differences in menstrual cycle characteristics and associated symptoms by age in a large global cohort of period tracking application users. This work aims to contribute to our knowledge and understanding of female physiology at varying stages of reproductive aging.Methods This cohort study included self-reported menstrual cycle and symptom information in a sample of Flo application users aged 18-55. Cycle and period length and their variability, and frequency of menstrual cycle symptom logs are described by age of user.Results Based on data logged by over 19 million global users of the Flo app, the length of the menstrual cycle and period show clear age associated patterns. With higher age, cycles tend to get shorter (Cycle length: D̄ = 1.85 days, Cohen’s D= 0.59) and more variable (Cycle length SD: D̄ = 0.42 days, Cohen’s D= 0.09), until close to the chronological age (40-44) suggesting menopausal transition, when both cycles and periods become longer (Cycle length: D̄ = 0.86 days, t=48.85, Cohen’s D=0.26; Period length: D̄ =0.08, t=15.6, Cohen’s D=0.07) and more variable (Cycle length SD: D̄ =2.80 days, t=111.43, d=0.51; Period length SD: D̄ =0.23 days, t=67.81, Cohen’s D=0.31). The proportion of individuals with irregular cycles was highest in participants aged 51-55 (44.7%), and lowest in the 36-40 age group (28.3%). The spectrum of common menstrual cycle related symptoms also varies with age. Frequency of logging of cramps and acne is lower in older participants, while logs of headache, backache, stress and insomnia are higher in older users. Other symptoms show different patterns, such as breast tenderness and fatigue peaking between the ages of 20-40, or mood swings being most frequently logged in the youngest and oldest users.Conclusion The menstrual cycle, and related symptoms are not static throughout the lifespan. Understanding these age related differences in cycle characteristics and symptoms is important in understanding how best to care for and improve daily experience for menstruators across the reproductive life span.Competing Interest StatementAC, AW, LZ, and AK are employees of Flo Health. AC, LZ, AW, AK hold equity interests in Flo Health. LP, CP and FG are consultants for Flo Health.Funding StatementThis study was funded by Flo HealthAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by an independent ethics review board (Western Copernicus Group Independent Review Board - WCG IRB, number 20226050). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study cannot be shared due to privacy restrictions.